Tools and technologies enabling healthcare
2 known investors
RareCan provides tumour genomic analysis and plain-language interpretation to help people living with rare or less common cancers understand their tumour biology and identify relevant UK clinical trials and treatment options. It serves patients, particularly those who have exhausted standard treatments, offering personalised reports and clarity about their care options.
BiotechDigital HealthHealthtech